LawrenceS.MorseMD
Ophthalmology • Sacramento, CARetinal Disease
Professor Emeritus, Ophthalmology, UC, Davis School of Medicine
Dr. Morse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4860 Y St
Suite 2400, Ophthalmology & Vision Science
Sacramento, CA 95817Phone+1 916-734-6962Fax+1 916-734-6197
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 1985 - 1988- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1982 - 1985
David Geffen School of Medicine at UCLAClass of 1982
Certifications & Licensure
CA State Medical License 1983 - 2024- CA State Medical License 1983 - 2022
NV State Medical License 1994 - 1997
NC State Medical License 1988 - 1990
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) Start of enrollment: 2009 Aug 01
- ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) Start of enrollment: 2010 Sep 01
- Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 35 citationsDensity-dependent expression of FGF-2 in response to oxidative stress in RPE cells in vitro.Mitsumasa Wada, Claire M. Gelfman, Hiroshi Matsunaga, Mitra Alizadeh, Lawrence S Morse
Current Eye Research. 2001-09-01 - 5 citationsClinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema.Lawrence S Morse, Linda Yau, Lisa Tuomi
BMJ Open Ophthalmology. 2019-10-01 - 10 citationsEpithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.David G. Telander, Alfred K. Yu, Krisztina I. Forward, Shawn A. Morales, Lawrence S Morse
Investigative Ophthalmology & Visual Science. 2016-06-01
Press Mentions
Patterns and Predictors of Successful Treatment Discontinuation in Retinal Vein Occlusions with Macular Edema in the Real WorldFebruary 24th, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
